David B. Cluck
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 7
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 5
- Epidemiology 10
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Co-authors
- Paul Lewis (6 shared papers)Emily L. Heil (1 shared paper)Jonathan P. Moorman (3 shared papers)Justin M Spivey (1 shared paper)Daniel B. Chastain (13 shared papers)Eric F. Egelund (1 shared paper)Spencer H. Durham (2 shared papers)Elizabeth M Sherman (2 shared papers)
- Journals
- Open Forum Infectious Diseases (5 papers)Annals of Pharmacotherapy (5 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Therapeutic Advances in Infectious Disease (3 papers)American Journal of Health-System Pharmacy (2 papers)
- Partner nations
- United States
In The Last Decade
David B. Cluck
30 papers receiving 291 citations
Peers
Comparison fields: 5 of 76
- Applied Microbiology and Biotechnology 35
- Molecular Medicine 64
- Internal Medicine 29
- Virology 30
- Infectious Diseases 116
Countries citing papers authored by David B. Cluck
This map shows the geographic impact of David B. Cluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Cluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Cluck more than expected).
Fields of papers citing papers by David B. Cluck
This network shows the impact of papers produced by David B. Cluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Cluck. The network helps show where David B. Cluck may publish in the future.
Co-authors
The 25 scholars most cited alongside David B. Cluck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 55 | |
| 2 | 2015 | 52 | |
| 3 | 2019 | 35 | |
| 4 | 2016 | 21 | |
| 5 | 2017 | 20 | |
| 6 | 2016 | 20 | |
| 7 | 2018 | 9 | |
| 8 | 2019 | 9 | |
| 9 | 2015 | 9 | |
| 10 | 2019 | 7 | |
| 11 | 2025 | 6 | |
| 12 | 2019 | 5 | |
| 13 | 2017 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2012 | 4 | |
| 16 | 2017 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2018 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2023 | 3 |
About David B. Cluck
David B. Cluck is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Clinical Biochemistry and Virology, having authored 35 papers that have together received 296 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (35 citations), Molecular Medicine (64 citations), Internal Medicine (29 citations), Virology (30 citations) and Infectious Diseases (116 citations). David B. Cluck has collaborated with scholars based in United States. Frequent co-authors include Paul Lewis, Emily L. Heil, Jonathan P. Moorman, Justin M Spivey, Daniel B. Chastain, Eric F. Egelund, Spencer H. Durham, Elizabeth M Sherman, John Williamson and Melissa E. Badowski. Their work appears in journals such as Open Forum Infectious Diseases, Annals of Pharmacotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Therapeutic Advances in Infectious Disease and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.